Symposium:
274. New Anti-Infective Clinical Trials that Will Change Your Practice
Saturday, October 7, 2017: 2:00 PM-3:30 PM
Room: 11AB

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss the results and methods of recent trials in antivirals
  • describe the results and methods of recent trials in antibacterials
  • identify the results and methods of recent trials in antifungals

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Infectious diseases pediatricians, Infectious diseases physicians, Medical students and residents, Members-in-training, Microbiologists, Nurses, Pharmacists, Public health practitioners, Researchers, Scientists

Tracks: Investigative ID, Adult ID, Pediatric ID, Trainee


Moderators:  David Van Duin, MD, PhD, University of North Carolina and Francisco M. Marty, MD, FIDSA, Brigham and Women's Hospital

Presentations:
2:00 PM
Recent Trials in Non-HIV Antivirals
Francisco M. Marty, MD, FIDSA

2:25 PM
Recent Trials in Antibacterials
Susan J. Rehm, MD, FIDSA

2:50 PM
Recent Trials in Antifungals
Thomas Patterson, MD, FIDSA, FACP

3:15 PM
Panel Discussion

CME Credits: Maximum of 1.50 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-17-319-L01-P

Disclosures:

D. Van Duin, Astellas: Scientific Advisor , Consulting fee
Achaogen: Scientific Advisor , Consulting fee
Allergan: Scientific Advisor , Consulting fee
MedImmune: Scientific Advisor , Consulting fee
Shionogi: Scientific Advisor , Consulting fee

F. M. Marty, Astellas Pharma US: Consultant and Grant Investigator , Consulting fee and Grant recipient
Chimerix: Consultant and Grant Investigator , Consulting fee and Grant recipient
Fate Therapeutics: Scientific Advisor , Consulting fee
Gilead Sciences: Consultant and Grant Investigator , Consulting fee and Grant recipient
LFB: Consultant , Consulting fee
Merck: Consultant , Grant Investigator and Scientific Advisor , Consulting fee and Grant recipient
Roche Molecular Systems: Consultant , Consulting fee
Shire: Consultant and Grant Investigator , Consulting fee and Grant recipient

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.